Science

AddToAny

Google+ Facebook Twitter Twitter

Spherocytes and irregularly contracted cells

Barbara J. Bain, Professor of Diagnostic Haematology and Honorary Consultant Haematologist, analyses spherocytes and irregularly contracted cells.

Spherocytes and irregularly contracted cells have morphological similarities but also differences. Their clinical significance is quite different, so it is important to make a distinction. Both cell types have reduced central pallor indicating that the normal disciform shape has been lost. However, spherocytes have a perfectly circular outline (Fig. 1, top right) whereas irregularly contracted cells have an irregular outline (Fig. 2, middle right).

Spherocyte formation

Spherocytosis results from an inherited or an acquired abnormality of the red cell membrane. Spherocytes are formed when there is loss of red cell membrane with the cell volume being fairly well preserved. A distinction should be drawn between spherocytes and microspherocytes, the latter resulting from red cell fragmentation in which there is loss of cell volume but with a disproportionate loss of membrane.

They are also sometimes known as spheroschistocytes. Causes of both are shown in Table 1 (below). Hereditary spherocytosis can result from a mutation in a variety of genes encoding ankyrin (ANK1), β spectrin (SPTB), the red cell membrane protein designated band 3 (SLC4A1), the α spectrin gene (SPTA) or the protein 4.2 (palladin) gene (EPB42). As the result of the mutation, there is reduced synthesis of the protein in question. This leads to loss of the normal tethering of the lipid bilayer to the underlying cytoskeleton so that pieces of the membrane become detached. In the immune causes of spherocytosis (autoimmune, alloimmune and drug-induced immune) the mechanism is recognition by splenic macrophages of immunoglobulin or complement components bound to the red cell membrane with resultant removal of some of the membrane by the macrophage.

Please click here to read the full article.

Image credit |Shutterstock

Related Articles

Transfusion: training hub

Jill Caulfield, Transfusion 2024 Education Development Lead at NHS Blood and Transplant, introduces a “one-stop shop” of training resources.

VR-headset - CREDIT -getty

Improving transfusion with training

Ruth Evans and Laura Eastwood from NHS Blood and Transplant discuss virtual reality training for blood transfusion testing.

red blood cells CREDIT-iStock-1227353965

Casestudy acquired protein s deficiency

Healthcare Science Section Lead in Haematology and Haemostasis Michelle Bolam presents a case study in which a two-year-old presented with an unprovoked extensive deep vein thrombosis.

paper cuts - CREDIT - Richard-Gleed

DNA: Cutting the future of genome editing

The latest CRISPR-Cas technology has been used to eliminate all traces of HIV from infected cells in the lab. Here we look at how gene editing could revolutionise clinical treatments and ask what the limitations are for its future use.

Top